Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Madagascar Green Product (MGP) is a leading agricultural biotechnology company based in Madagascar, specializing in the large-scale cultivation and sourcing of medicinal plants, most notably Artemisia annua. The company serves as a critical upstream partner in the global pharmaceutical supply chain by producing high-quality artemisinin, the essential raw material for Artemisinin-based Combination Therapies (ACTs) used to treat malaria. MGP operates an extensive outgrower model, managing a network of over 10,000 smallholder farmers to ensure a sustainable and traceable supply of botanical extracts. By bridging traditional agriculture with industrial pharmaceutical standards, MGP plays a vital role in stabilizing the availability and cost of life-saving anti-malarial medications worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Madagascar Green Product.